1
|
Podolakova K, Barak L, Jancova E, Stanik J, Sebekova K, Podracka L. The Bright Side of Skin Autofluorescence Determination in Children and Adolescents with Newly Diagnosed Type 1 Diabetes Mellitus: A Potential Predictor of Remission? Int J Environ Res Public Health 2022; 19:11950. [PMID: 36231246 PMCID: PMC9565643 DOI: 10.3390/ijerph191911950] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 09/01/2022] [Revised: 09/17/2022] [Accepted: 09/18/2022] [Indexed: 06/16/2023]
Abstract
Skin autofluorescence (SAF) is a noninvasive method reflecting tissue accumulation of advanced glycation end products (AGEs). We investigated whether, in newly diagnosed children and adolescents with type 1 diabetes (T1D), this surrogate marker of long-term glycemia is associated with markers of the early manifestation phase, residual secretion capacity of the ß-cells, and the occurrence of remission. SAF was measured in 114 children and adolescents (age: 8.0 ± 4.5 years, 44% girls) at the time of T1D diagnosis, and related to HbA1c, C-peptide, diabetic ketoacidosis, and remission. 56 patients were followed up for 1 year. Seventy-four sex- and age-matched healthy individuals served as controls. SAF was higher in the T1D group compared with controls (1.0 ± 0.2 vs. 0.9 ± 0.2, p < 0.001). At the time of diagnosis, SAF correlated with HbA1c (r = 0.285, p = 0.002), was similar in patients with and without ketoacidosis, and was lower in the remitters compared with non-remitters (0.95 ± 0.18 vs. 1.04 ± 0.26, p = 0.027). Unlike HbA1c, SAF was an independent predictor of remission (∆R2 = 0.051, p = 0.004). Former studies consider SAF in diabetic patients as a tool to identify individuals at an increased risk of chronic complications. Here we show that determination of SAF at the time of T1D diagnosis might potentially predict remission, at least in children.
Collapse
Affiliation(s)
- Kristina Podolakova
- Department of Pediatrics, Medical Faculty of Comenius University and National Institute for Children’s Diseases, Limbova 1, 83340 Bratislava, Slovakia
| | - Lubomir Barak
- Department of Pediatrics, Medical Faculty of Comenius University and National Institute for Children’s Diseases, Limbova 1, 83340 Bratislava, Slovakia
| | - Emilia Jancova
- Department of Pediatrics, Medical Faculty of Comenius University and National Institute for Children’s Diseases, Limbova 1, 83340 Bratislava, Slovakia
| | - Juraj Stanik
- Department of Pediatrics, Medical Faculty of Comenius University and National Institute for Children’s Diseases, Limbova 1, 83340 Bratislava, Slovakia
- Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Dubravska Cesta 9, 84505 Bratislava, Slovakia
| | - Katarina Sebekova
- Institute of Molecular Biomedicine, Medical Faculty of Comenius University, Sasinkova 4, 81108 Bratislava, Slovakia
| | - Ludmila Podracka
- Department of Pediatrics, Medical Faculty of Comenius University and National Institute for Children’s Diseases, Limbova 1, 83340 Bratislava, Slovakia
| |
Collapse
|
2
|
Sebekova K, Gurecka R, Podracka L. Asymptomatic Hyperuricemia Associates with Cardiometabolic Risk Indicators in Overweight/Obese but Not in Lean Adolescents. Diabetes Metab Syndr Obes 2020; 13:3977-3992. [PMID: 33149637 PMCID: PMC7603647 DOI: 10.2147/dmso.s267123] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/16/2020] [Accepted: 08/15/2020] [Indexed: 12/15/2022] Open
Abstract
PURPOSE In overweight/obese adolescents, asymptomatic hyperuricemia is associated with increased prevalence of metabolic syndrome, its components, and a higher cardiometabolic risk. Whether similar associations exist in lean hyperuricemic adolescents is unknown. SUBJECTS AND METHODS In 2424 adolescents (51.9% females) aged 16-19 years, anthropometric variables, blood pressure, uric acid, glucose, insulin, lipid profile, inflammatory markers, and renal function were determined. Continuous cardiometabolic score was calculated. Normouricemic vs hyperuricemic subjects were compared among lean and overweight/obese individuals of both sexes. RESULTS Females (5.4%) and males (13.3%) presented with hyperuricemia; among them 63% of females and 53% of males were lean. In both sexes, hyperuricemic lean and hyperuricemic overweight/obese adolescents displayed similar uric acid concentrations (eg, males: 455±30 vs 461±32 µmol/L, respectively, p=0.933). Lean normouricemic adolescents manifested significantly lower uric acid levels than their overweight/obese peers (eg, males: 333±46 vs 357±41 µmol/L, respectively, p<0.001). Lean normouricemic and hyperuricemic subjects presented similar cardiometabolic score (eg, males: 2.60±0.67 vs 2.64±0.60, respectively, p=0.998); among overweight/obese adolescents those with hyperuricemia displayed higher scores compared with their normouricemic counterparts (eg, males: 3.36±1.04 vs 4.21±1.65, respectively, p<0.001). A decision-tree model revealed phenotypes associated with higher uricemia, however, distribution of individuals with hyperuricemia among phenotypes was random. CONCLUSION In lean adolescents, hyperuricemia is not associated with cardiometabolic profile indicating an increased risk. Existence of this rather prevalent phenotype remains undetected unless lean and overweight/obese subjects are analyzed separately. Longitudinal studies are needed to elucidate the potential clinical consequences of asymptomatic hyperuricemia in lean subjects in later life.
Collapse
Affiliation(s)
- Katarina Sebekova
- Institute of Molecular BioMedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia
- Correspondence: Katarina Sebekova Institute of Molecular BioMedicine, Medical Faculty, Comenius University, Sasinkova 4, 811 08 Bratislava, SlovakiaTel +421-2-9011-9429Fax +421-2-9011-9631 Email
| | - Radana Gurecka
- Institute of Molecular BioMedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia
- Institute of Medical Physics, Biophysics, Informatics and Telemedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia
| | - Ludmila Podracka
- Department of Pediatrics, Faculty of Medicine, Comenius University, Bratislava, Slovakia
- The National Institute of Children’s Health, Bratislava, Slovakia
| |
Collapse
|
3
|
Sebekova K, Sebek J. Continuous metabolic syndrome score (siMS) enables quantification of severity of cardiometabolic affliction in individuals not presenting with metabolic syndrome. ACTA ACUST UNITED AC 2018; 119:675-678. [DOI: 10.4149/bll_2018_121] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
4
|
Sebekova K, Krivosikova Z, Gajdos M, Podracka L. Vitamin D status in apparently healthy medication-free Slovaks: Association to blood pressure, body mass index, self-reported smoking status and physical activity. ACTA ACUST UNITED AC 2017; 117:702-709. [PMID: 28127966 DOI: 10.4149/bll_2016_135] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
BACKGROUND Vitamin D plays a role in protecting against chronic degenerative diseases. Slovak adults present one of the highest cardiovascular mortality rates among 27 EU countries. OBJECTIVES We asked whether the 25(OH)D3 status in apparently healthy medication-free Slovaks deteriorates upon ageing, and in the presence of cardiometabolic risk factors. METHODS We studied the impact of blood pressure, overweight/obesity, smoking, and physical activity on 25(OH)D3 levels determined using RIA method in 578 (5-81 years old) subjects. RESULTS The average level of 25(OH)D3 was 36±17 ng/ml. A proportion of 15 % of participants were 25(OH)D3‑deficient (≤20 ng/ml), 26 % presented insufficient (20-to-30 ng/ml), and 59 % satisfactory (> 30 ng/ml) levels. Neither mean 25(OH)D3 levels, nor the prevalence of hypovitaminosis D showed age dependence. Physically active normotensive non-smokers presented the highest (41±19 ng/ml), and their smoking counterparts with elevated BP the lowest 25(OH)D3 levels (30±12 ng/ml). CONCLUSION In apparently healthy medication-free Slovaks the prevalence of hypovitaminosis D is high. Vitamin D status does not deteriorate in course of healthy ageing. Physical activity, normotension, and non-smoking status are associated with favorable vitamin D status while low 25(OH)D3 levels are associated with multiple cardiometabolic risk factors. Further studies in subjects at high cardiovascular risk are needed to elucidate the potential association of hypovitaminosis D with high cardiovascular mortality in Slovak adults (Tab. 1, Fig. 4, Ref. 42).
Collapse
|
5
|
Madaric J, Valachovicova M, Paulis L, Pribojova J, Mateova R, Sebekova K, Postulkova L, Madaricova T, Bucova M, Mistrik M, Vulev I. Improvement in asymmetric dimethylarginine and oxidative stress in patients with limb salvage after autologous mononuclear stem cell application for critical limb ischemia. Stem Cell Res Ther 2017; 8:165. [PMID: 28697789 PMCID: PMC5506609 DOI: 10.1186/s13287-017-0622-2] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2017] [Revised: 06/19/2017] [Accepted: 06/26/2017] [Indexed: 11/10/2022] Open
Abstract
Background Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, acts as an inhibitor of angiogenesis and is associated with an increased risk of cardiovascular mortality. Administration of stem cells may affect endogenous mechanisms that regulate ADMA production and metabolism. The aim of the present study was to analyze ADMA concentration and changes in oxidative stress in patients with advanced critical limb ischemia (CLI) after bone marrow-derived mononuclear cell (BM-MNC) therapy. Methods Fifty patients (age 64 ± 11 years, 44 males, 6 females) with advanced CLI (Rutherford category 5 or 6) not eligible for revascularization were treated by intramuscular (n = 25) or intra-arterial (n = 25) injection of 40 ml BM-MNC concentrate. Patients with limb salvage and improved wound healing after 6 months were considered responders to cell therapy. The concentrations of markers of oxidative stress and angiogenesis were analyzed before, and at 3 and 6 months after BM-MNC delivery. Results At 6-month follow-up, four patients died of reasons unrelated to stem cell therapy. Among the survivors, 80% (37/46) showed limb salvage and improved wound healing. At 6 months follow-up, ADMA concentration significantly decreased in patients with limb salvage (1.74 ± 0.66 to 0.90 ± 0.49 μmol/L, p < 0.001), in parallel with decreased tumor necrosis factor (TNF)-α (2.22 ± 0.16 to 1.94 ± 0.38 pg/ml, p < 0.001), and increased reduced glutathione (6.96 ± 3.1 to 8.67 ± 4.2 μmol/L, p = 0.02), superoxide dismutase activity (168 ± 50 to 218 ± 37 U/L, p = 0.002), and coenzyme Q10 concentration (468 ± 182 to 598 ± 283 μg/L, p = 0.02). The number of delivered BM-MNCs significantly correlated with the decrease in ADMA concentration at 3 months (p = 0.004, r = −0.48) and the decrease in TNF-α concentration at 6 months (p = 0.03, r = −0.44) after cell delivery. ADMA or TNF-α improvement did not correlate with the number of applied CD34+ cells, C-reactive protein concentration, leukocyte count, or the dose of atorvastatin. Conclusions The therapeutic benefit of BM-MNC therapy is associated with reduced ADMA levels and oxidative stress. Regulation of the ADMA-nitric oxide axis and improved antioxidant status may be involved in the beneficial effects of stem cell therapy. Trial registration The study was approved and retrospectively registered by ISRCTN registry, ISRCTN16096154. Registered on 26 July 2016.
Collapse
Affiliation(s)
- Juraj Madaric
- National Institute of Cardiovascular Diseases, Slovak Medical University, Bratislava, Slovakia.
| | | | - Ludovit Paulis
- Institute of Molecular BioMedicine, Faculty of Medicine Comenius University, Bratislava, Slovakia
| | | | | | - Katarina Sebekova
- Institute of Molecular BioMedicine, Faculty of Medicine Comenius University, Bratislava, Slovakia
| | - Luba Postulkova
- National Institute of Cardiovascular Diseases, Slovak Medical University, Bratislava, Slovakia
| | - Terezia Madaricova
- National Institute of Cardiovascular Diseases, Slovak Medical University, Bratislava, Slovakia
| | - Maria Bucova
- Institute of Imunology, Faculty of Medicine Comenius University, Bratislava, Slovakia
| | - Martin Mistrik
- Clinic of Haematology and Transfusiology, Faculty Hospital, Bratislava, Slovakia
| | - Ivan Vulev
- National Institute of Cardiovascular Diseases, Slovak Medical University, Bratislava, Slovakia
| |
Collapse
|
6
|
Malycha J, Bonnici T, Sebekova K, Petrinic T, Young D, Watkinson P. Variables associated with unplanned general adult ICU admission in hospitalised patients: protocol for a systematic review. Syst Rev 2017; 6:67. [PMID: 28351424 PMCID: PMC5370455 DOI: 10.1186/s13643-017-0456-0] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/24/2016] [Accepted: 03/14/2017] [Indexed: 11/12/2022] Open
Abstract
BACKGROUND Failure to promptly identify deterioration in hospitalised patients is associated with delayed admission to intensive care units (ICUs) and poor outcomes. Existing vital sign-based Early Warning Score (EWS) algorithms do not have a sufficiently high positive predictive value to be used for automated activation of an ICU outreach team. Incorporating additional patient data might improve the predictive power of EWS algorithms; however, it is currently not known which patient data (or variables) are most predictive of ICU admission. We describe the protocol for a systematic review of variables associated with ICU admission. METHODS/DESIGN MEDLINE, EMBASE, CINAHL and the Cochrane Library, including Cochrane Database of Systematic Reviews and the Cochrane Central Register of Controlled Trials (CENTRAL) will be searched for studies that assess the association of routinely recorded variables associated with subsequent unplanned ICU admission. Only studies involving adult patients admitted to general ICUs will be included. We will extract data relating to the statistical association between ICU admission and predictor variables, the quality of the studies and the generalisability of the findings. DISCUSSION The results of this review will aid the development of future models which predict the risk of unplanned ICU admission. SYSTEMATIC REVIEW REGISTRATION PROSPERO: CRD42015029617.
Collapse
Affiliation(s)
- James Malycha
- Kadoorie Centre for Critical Care Research and Education, John Radcliffe Hospital, Level 3, Headley Way, Oxford, OX3 9DU UK
| | - Tim Bonnici
- Kadoorie Centre for Critical Care Research and Education, John Radcliffe Hospital, Level 3, Headley Way, Oxford, OX3 9DU UK
| | - Katarina Sebekova
- Kadoorie Centre for Critical Care Research and Education, John Radcliffe Hospital, Level 3, Headley Way, Oxford, OX3 9DU UK
| | - Tatjana Petrinic
- University of Oxford, Bodleian Health Care Libraries, Academic Centre, John Radcliffe Hospital, Level 3, Headley Way, Oxford, OX3 9DU UK
| | - Duncan Young
- Kadoorie Centre for Critical Care Research and Education, John Radcliffe Hospital, Level 3, Headley Way, Oxford, OX3 9DU UK
| | - Peter Watkinson
- Kadoorie Centre for Critical Care Research and Education, John Radcliffe Hospital, Level 3, Headley Way, Oxford, OX3 9DU UK
| |
Collapse
|
7
|
Dusinska M, Boland S, Saunders M, Juillerat-Jeanneret L, Tran L, Pojana G, Marcomini A, Volkovova K, Tulinska J, Knudsen LE, Gombau L, Whelan M, Collins AR, Marano F, Housiadas C, Bilanicova D, Halamoda Kenzaoui B, Correia Carreira S, Magdolenova Z, Fjellsbø LM, Huk A, Handy R, Walker L, Barancokova M, Bartonova A, Burello E, Castell J, Cowie H, Drlickova M, Guadagnini R, Harris G, Harju M, Heimstad ES, Hurbankova M, Kazimirova A, Kovacikova Z, Kuricova M, Liskova A, Milcamps A, Neubauerova E, Palosaari T, Papazafiri P, Pilou M, Poulsen MS, Ross B, Runden-Pran E, Sebekova K, Staruchova M, Vallotto D, Worth A. Towards an alternative testing strategy for nanomaterials used in nanomedicine: lessons from NanoTEST. Nanotoxicology 2016; 9 Suppl 1:118-32. [PMID: 25923349 DOI: 10.3109/17435390.2014.991431] [Citation(s) in RCA: 63] [Impact Index Per Article: 7.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
In spite of recent advances in describing the health outcomes of exposure to nanoparticles (NPs), it still remains unclear how exactly NPs interact with their cellular targets. Size, surface, mass, geometry, and composition may all play a beneficial role as well as causing toxicity. Concerns of scientists, politicians and the public about potential health hazards associated with NPs need to be answered. With the variety of exposure routes available, there is potential for NPs to reach every organ in the body but we know little about the impact this might have. The main objective of the FP7 NanoTEST project ( www.nanotest-fp7.eu ) was a better understanding of mechanisms of interactions of NPs employed in nanomedicine with cells, tissues and organs and to address critical issues relating to toxicity testing especially with respect to alternatives to tests on animals. Here we describe an approach towards alternative testing strategies for hazard and risk assessment of nanomaterials, highlighting the adaptation of standard methods demanded by the special physicochemical features of nanomaterials and bioavailability studies. The work has assessed a broad range of toxicity tests, cell models and NP types and concentrations taking into account the inherent impact of NP properties and the effects of changes in experimental conditions using well-characterized NPs. The results of the studies have been used to generate recommendations for a suitable and robust testing strategy which can be applied to new medical NPs as they are developed.
Collapse
Affiliation(s)
- M Dusinska
- Health Effects Laboratory-MILK, NILU - Norwegian Institute for Air Research , Kjeller , Norway
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Bartakova V, Kollarova R, Kuricova K, Sebekova K, Belobradkova J, Kankova K. Serum carboxymethyl-lysine, a dominant advanced glycation end product, is increased in women with gestational diabetes mellitus. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2016; 160:70-5. [DOI: 10.5507/bp.2015.045] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2015] [Accepted: 09/10/2015] [Indexed: 11/23/2022] Open
|
9
|
Heidland A, Fazeli G, Klassen A, Sebekova K, Hennemann H, Bahner U, Di Iorio B. Neuromuscular electrostimulation techniques: historical aspects and current possibilities in treatment of pain and muscle waisting. Clin Nephrol 2013; 79 Suppl 1:S12-S23. [PMID: 23249528] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/01/2023] Open
Abstract
Application of electricity for pain treatment dates back to thousands of years BC. The Ancient Egyptians and later the Greeks and Romans recognized that electrical fishes are capable of generating electric shocks for relief of pain. In the 18th and 19th centuries these natural producers of electricity were replaced by man-made electrical devices. This happened in following phases. The first was the application of static electrical currents (called Franklinism), which was produced by a friction generator. Christian Kratzenstein was the first to apply it medically, followed shortly by Benjamin Franklin. The second phase was Galvanism. This method applied a direct electrical current to the skin by chemical means, applied a direct and pulsed electrical current to the skin. In the third phase the electrical current was induced intermittently and in alternate directions (called Faradism). The fourth stage was the use of high frequency currents (called d'Arsonvalisation). The 19th century was the "golden age" of electrotherapy. It was used for countless dental, neurological, psychiatric and gynecological disturbances. However, at beginning of the 20th century electrotherapy fell from grace. It was dismissed as lacking a scientific basis and being used also by quacks and charlatans for unserious aims. Furthermore, the development of effective analgesic drugs decreased the interest in electricity. In the second half of the 20th century electrotherapy underwent a revival. Based on animal experiments and clinical investigations, its neurophysiological mechanisms were elucidated in more details. The pain relieving action of electricity was explained in particular by two main mechanisms: first, segmental inhibition of pain signals to the brain in the dorsal horn of the spinal cord and second, activation of the descending inhibitory pathway with enhanced release of endogenous opioids and other neurochemical compounds (serotonin, noradrenaline, gamma aminobutyric acid (GABA), acetylcholine and adenosine). The modern electrotherapy of neuromusculo- skeletal pain is based in particular on the following types: transcutaneous electrical nerve stimulation (TENS), percutaneous electrical nerve stimulation (PENS or electro-acupuncture) and spinal cord stimulation (SCS). In mild to moderate pain, TENS and PENS are effective methods, whereas SCS is very useful for therapy of refractory neuropathic or ischemic pain. In 2005, high tone external muscle stimulation (HTEMS) was introduced. In diabetic peripheral neuropathy, its analgesic action was more pronounced than TENS application. HTEMS appeared also to have value in the therapy of symptomatic peripheral neuropathy in end-stage renal disease (ESRD). Besides its pain-relieving effect, electrical stimulation is of major importance for prevention or treatment of muscle dysfunction and sarcopenia. In controlled clinical studies electrical myostimulation (EMS) has been shown to be effective against the sarcopenia of patients with chronic congestive heart disease, diabetes, chronic obstructive pulmonary disease and ESRD.
Collapse
Affiliation(s)
- August Heidland
- Department of Internal Medicine, University of Würzburg, Würzburg, Germany.
| | | | | | | | | | | | | |
Collapse
|
10
|
Heidland A, Sebekova K, Klassen A, Palkovits M. Mechanisms of Acute Uremic Encephalopathy: Early Activation of Fos and Fra-2 Gene Products in Different Nuclei/Areas of the Rat Brain. J Ren Nutr 2010; 20:S44-50. [DOI: 10.1053/j.jrn.2010.05.011] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
|
11
|
Heidland A, Klassen A, Sebekova K, Bahner U. Beginning of modern concept of inflammation: the work of Friedrich Daniel von Recklinghausen and Julius Friedrich Cohnheim. J Nephrol 2009; 22 Suppl 14:71-79. [PMID: 20013736] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
In Rudolf Virchow's concept of inflammation, the basic alterations were derived from connective tissue cells, which underwent a marked metamorphosis. This cell-based and static conception was fundamentally broadened and, in part, refuted in the ensuing decade by 2 of his scholars. Friedrich Daniel von Recklinghausen characterized the pus cells in acute inflammation and made the seminal observation of their contractility and mobility. He was the first who described the wandering leukocytes which were demonstrated in particular in experimental keratitis. He also showed that pus cells could migrate from the places of their origin in the interstitium to other tissues and epithelial cells. Von Recklinghausen in addition contributed to the concept of phagocytosis. The work of Julius Friedrich Cohnheim was focused on the mechanisms involved in the extravasation of leukocytes from the blood vessels in the inflamed mesentery of the frog and carefully described the time-dependent alterations: dilatation of the arteries and veins, adhesion of colorless cells to the endothelial cells, and the subsequent transmigration from the capillaries and venules into the interstitial space. In the last few decades, experimental and clinical studies using modern techniques have fully confirmed and extended these basic observations made by von Recklinghausen and Cohnheim more than 100 years ago.
Collapse
Affiliation(s)
- August Heidland
- Department of Internal Medicine, University of Würzburg, Würzburg, Germany.
| | | | | | | |
Collapse
|
12
|
Dusinska M, Dusinska M, Fjellsbø LM, Magdolenova Z, Rinna A, Runden Pran E, Bartonova A, Heimstad ES, Harju M, Tran L, Ross B, Juillerat L, Halamoda Kenzaui B, Marano F, Boland S, Guadaginini R, Saunders M, Cartwright L, Carreira S, Whelan M, Kelin CH, Worth A, Palosaari T, Burello E, Housiadas C, Pilou M, Volkovova K, Tulinska J, Kazimirova A, Barancokova M, Sebekova K, Hurbankova M, Kovacikova Z, Knudsen L, Poulsen MS, Mose T, Vilà M, Gombau L, Fernandez B, Castell J, Marcomini A, Pojana G, Bilanicova D, Vallotto D. Testing strategies for the safety of nanoparticles used in medical applications. Nanomedicine (Lond) 2009; 4:605-7. [DOI: 10.2217/nnm.09.47] [Citation(s) in RCA: 53] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Affiliation(s)
- Maria Dusinska
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - M Dusinska
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - LM Fjellsbø
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - Z Magdolenova
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - A Rinna
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - E Runden Pran
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - A Bartonova
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - ES Heimstad
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - M Harju
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - L Tran
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - B Ross
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - L Juillerat
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - B Halamoda Kenzaui
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - F Marano
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - S Boland
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - R Guadaginini
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - M Saunders
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - L Cartwright
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - S Carreira
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - M Whelan
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - CH Kelin
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - A Worth
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - T Palosaari
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - E Burello
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - C Housiadas
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - M Pilou
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - K Volkovova
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - J Tulinska
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - A Kazimirova
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - M Barancokova
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - K Sebekova
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - M Hurbankova
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - Z Kovacikova
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - L Knudsen
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - MS Poulsen
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - T Mose
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - M Vilà
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - L Gombau
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - B Fernandez
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - J Castell
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - A Marcomini
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - G Pojana
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - D Bilanicova
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| | - D Vallotto
- Health Effects Group, Norwegian Institute for Air Research (NILU), Centre for Ecology and Economics, POB 100, Instituttvn. 18, N-2027 Kjeller, Norway
| |
Collapse
|
13
|
Dusinska M, Fjellsbo LM, Heimstad E, Harju M, Bartonova A, Tran L, Juillerat-Jeanneret L, Halamoda B, Marano F, Boland S, Saunders M, Cartwright L, Carreira S, Thawley S, Whelan M, Klein C, Housiadas C, Volkovova K, Tulinska J, Beno M, Sebekova K, Knudsen LE, Mose T, Castell JV, Vilà MR, Gombau L, Jepson M, Pojana G, Marcomini A. Development of methodology for alternative testing strategies for the assessment of the toxicological profile of nanoparticles used in medical diagnostics. NanoTEST – EC FP7 project. ACTA ACUST UNITED AC 2009. [DOI: 10.1088/1742-6596/170/1/012039] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
14
|
Palkovits M, Sebekova K, Gallatz K, Boor P, Sebekova K, Klassen A, Bahner U, Heidland A. Neuronal activation in the CNS during different forms of acute renal failure in rats. Neuroscience 2009; 159:862-82. [DOI: 10.1016/j.neuroscience.2008.12.062] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2008] [Revised: 12/20/2008] [Accepted: 12/24/2008] [Indexed: 10/21/2022]
|
15
|
Rabbani N, Sebekova K, Sebekova K, Heidland A, Thornalley PJ. Accumulation of free adduct glycation, oxidation, and nitration products follows acute loss of renal function. Kidney Int 2007; 72:1113-21. [PMID: 17728703 DOI: 10.1038/sj.ki.5002513] [Citation(s) in RCA: 65] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
Glycation, oxidation, and nitration of endogenous proteins occur spontaneously and these modifications are also present in foods. Increased levels of these chemical changes are associated with chronic renal failure; however, little is known about acute kidney failure. We measured these modifications of plasma protein and related free adducts in plasma following bilateral nephrectomy and bilateral ureteral obstruction. Advanced glycation end-product (AGE) residues of plasma protein were increased 3 h post-surgery, and thereafter slowly decreased in all groups, reflecting changes in plasma protein synthesis and transcapillary flow post-surgery. Ureteral ligation increased oxidation and nitration adduct residues. There were, however, marked increases in AGE, dityrosine, or 3-nitrotyrosine free adducts in both nephrectomized and ureter-ligated rats compared to rats that had undergone sham operations. There were lower modified adduct concentrations in the ureter-ligated compared to the nephrectomized rats, reflecting residual glomerular filtration and tubular removal. There was no increase in glycated, oxidized, and nitrated proteins. Glyoxal and methylglyoxal were also increased in both renal failure models. Our study shows that the acute loss of renal function and urinary excretion leads to the accumulation of AGE, oxidation, and nitration free adducts in the plasma.
Collapse
Affiliation(s)
- N Rabbani
- Clinical Sciences Research Institute, Warwick Medical School, University of Warwick, Coventry, UK
| | | | | | | | | |
Collapse
|
16
|
Abstract
Excess body weight may be associated with various functional/structural lesions of the kidney. The spectrum ranges from glomerulomegaly with or without focal or segmental glomerulosclerosis, to diabetic nephropathy, to carcinoma of the kidney and nephrolithiasis. The first sign of renal injury is microalbuminuria or frank proteinuria, in particular in the presence of hypertension. The occurrence of microalbuminuria and/or chronic kidney insufficiency (glomerular filtration rate < 60 mL/min/1.73 m2) is related to the increasing number of components of the metabolic syndrome, ie, central obesity, elevated fasting blood glucose level, hypertriglycerides, low high-density lipoprotein cholesterol, and hypertension. In the long run, end-stage renal failure may develop. An increased body mass index is particularly harmful in patients with reduced renal functional mass (unilateral renal agenesis or nephrectomy) and other renal diseases (immunoglobulin A nephritis and chronic graft dysfunction after kidney transplantation). In the pathogenesis of obesity-associated glomerulopathy, hyperfiltration is of fundamental importance. The factors involved are energy intake (high protein and salt), hyperinsulinemia, and enhanced tubuloglomerular feedback because of increased sodium reabsorption. The adrenergic and renin-angiotensin-aldosterone systems as well as glucocorticoids are stimulated. In addition, several active proteins generated in the central adipose tissue, such as leptin, proinflammatory cytokines, plasminogen activator inhibitor-1, angiotensinogen, and growth factors (transforming growth factor-beta1), as well as low levels of the protective adiponectin, may contribute to renal injury. Of greatest importance is the development of hypertension and of diabetes, which are directly related to the severity of central obesity. Obesity-associated renal disease should be prevented or retarded by weight reduction following lifestyle modification (salt restriction, hypocaloric diet, aerobic exercise), or eventually by antiobesity medication or bariatric surgery. In the presence of glomerulopathy and/or hypertension, angiotensin converting enzyme inhibitors or angiotensin II type I receptor blockers are the drugs of choice to improve glomerular hyperfiltration.
Collapse
Affiliation(s)
- Przemyslaw Rutkowski
- Department of Nephrology, Transplantology, and Internal Diseases, Medical University of Gdansk, Poland
| | | | | | | | | |
Collapse
|
17
|
Abstract
In end-stage renal failure, genomic damage is enhanced. This has been shown both in the predialysis and dialysis phase by various biomarkers, such as micronuclei frequency and single cell gel electrophoresis in lymphocytes as well as with 8-hydroxy-2'-deoxyguanosine in leukocytes. There are also data about mitochondrial DNA deletions and chromosomal abnormalities. Genomic damage may be induced by a multitude of toxic factors and mutagens, in particular via enhanced generation of reactive oxygen species. In in vitro studies, incubation of tubular cells with various AGEs (carboxymethyllysine-BSA, AGE-BSA, and methylglyoxal-BSA) and angiotensin II resulted in a marked DNA damage. Coincubation with various antioxidants as well as the angiotensin II receptor blocker, candesartan, suppressed the toxic action. Moreover, an improved uremic state by daily hemodialysis ameliorated the genomic damage in lymphocytes, as compared to patients on conventional hemodialysis.
Collapse
Affiliation(s)
- Helga Stopper
- Department of Pharmacology and Toxicology, University of Wuerzburg, Wuerzburg, Germany
| | | | | | | | | |
Collapse
|
18
|
Kobras K, Schupp N, Nehrlich K, Adelhardt M, Bahner U, Vienken J, Heidland A, Sebekova K, Stopper H. Relation between Different Treatment Modalities and Genomic Damage of End-Stage Renal Failure Patients. Kidney Blood Press Res 2006; 29:10-7. [PMID: 16582572 DOI: 10.1159/000092482] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2005] [Accepted: 11/28/2005] [Indexed: 11/19/2022] Open
Abstract
BACKGROUND Patients with end-stage renal disease display enhanced genomic damage. We investigated the relation between genomic damage and different treatment modalities. METHODS In a longitudinal study two groups of patients were analyzed in monthly intervals. We assessed the initiation of hemodialysis in 5 conservatively treated patients, and a switch from hemodialysis to hemodiafiltration in 7 patients. DNA damage was investigated in peripheral blood lymphocytes by micronucleus frequency and by comet assay analysis. With regard to potential genotoxicity of advanced glycation end products (AGEs), levels of imidazolone A and AGE-associated fluorescence (AGE-FL) were determined. RESULTS The initiation of hemodialysis did not alter the genomic damage. In patients who switched from hemodialysis to hemodiafiltration, a small but significant reduction in the comet assay but not in the micronucleus frequency was observed. Elevated plasma levels of imidazolone A and AGE-FL were not influenced by the treatment modalities. CONCLUSION In our small patient group no major reduction of the elevated genomic damage could be reached. Disease factors not influenced by altered dialysis modalities may have contributed considerably in our patient group. The persisting high levels of DNA damage suggest a need for further improvement. Inhibiting AGE formation may be one promising way for the future.
Collapse
Affiliation(s)
- K Kobras
- Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany
| | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Fragedaki E, Nebel M, Schupp N, Sebekova K, Völkel W, Klassen A, Pischetsrieder M, Frischmann M, Niwa T, Vienken J, Heidland A, Stopper H. Genomic damage and circulating AGE levels in patients undergoing daily versus standard haemodialysis. Nephrol Dial Transplant 2005; 20:1936-43. [PMID: 15919695 DOI: 10.1093/ndt/gfh898] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND Patients with end-stage renal failure, whether on conservative or haemodialysis therapy, have a high incidence of DNA damage. It is not known if improved control of the uraemic state by daily haemodialysis (DHD) reduces DNA lesions. METHODS DNA damage in peripheral blood lymphocytes (PBLs) was evaluated in a cross-sectional study of 13 patients on DHD (2-3 h, 6 times/week), 12 patients on standard haemodialysis (SHD) therapy (4-5 h, 3 times/week) and 12 healthy age-matched volunteer controls. The biomarker of DNA damage used was micronucleus frequency. The assessed plasma parameters of microinflammation and oxidative stress were C-reactive protein (CRP), interleukin-6 (IL-6), neopterin, advanced oxidation protein products (AOPP), and homocysteine. We also measured plasma concentrations of the circulating advanced glycation end products (AGEs) MGI (methylglyoxal-derived imidazolinone), CML (carboxymethyllysine), imidazolone A (3-deoxyglucosone-derived imidazolinone) and AGE-associated fluorescence. RESULTS Compared to SHD, DHD was associated with significantly lower DNA damage, approaching the normal range. Micronuclei (MN) frequency averaged 29.1 MN+/-5.9/1000 binucleated (BN) cells in the SHD group, which is significantly elevated (P<0.01), 14.8 MN+/-4.0/1000 BN cells in the DHD group, and 13.2 MN+/-3.04/1000 BN cells in the controls. CRP and AOPP were in the normal range (and similar between the dialysis groups). In contrast, IL-6 and neopterin were significantly elevated, with lower values associated with DHD as compared with SHD. The increased levels of AGEs tended to be lower in the DHD group, reaching significance for CML and imidazolone A. CONCLUSIONS Overall, it was found that genomic damage in PBLs is lower in patients on DHD than in those on SHD. Lower plasma concentrations of uraemic toxins, including circulating AGEs, may account for the differences. To confirm these data, prospective clinical trials need to be performed.
Collapse
Affiliation(s)
- Evangelia Fragedaki
- Institute of Pharmacology and Toxicology, University of Würzburg, Versbacherstr. 9, D-97080 Würzburg, Germany
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Stopper H, Schupp N, Bahner U, Sebekova K, Klassen A, Heidland A. Genomic damage in end-stage renal failure: potential involvement of advanced glycation end products and carbonyl stress. Semin Nephrol 2005; 24:474-8. [PMID: 15490414 DOI: 10.1016/j.semnephrol.2004.06.025] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
In patients with chronic renal failure, genomic damage has been shown by numerous biomarkers, such as micronuclei frequency and comet assay (single-cell gel electrophoresis) in peripheral lymphocytes, 8-hydroxy 2'-deoxyguanosine (8-OH-dG) content in leukocytes, mitochondrial DNA deletions in skeletal muscle tissue and hair follicles, as well as in DNA repair mechanisms in freshly isolated lymphocytes after ultraviolet light exposure. In the pathogenesis of DNA damage--besides genetic influences, enhanced reactive oxygen species (ROS), and lipid peroxidation-the genotoxic potential of advanced glycation end products (AGEs) and reactive carbonyl compounds deserve special attention. In fact, reactions of glucose with DNA can lead to mutagenic DNA AGEs. In vitro, incubation of tubulus cells with various AGEs and methylglyoxal induces DNA damage, which is suppressed by antioxidants. This underlines the role played by oxidative stress in DNA damage.
Collapse
Affiliation(s)
- Helga Stopper
- Institute of Pharmacology and Toxicology, University of Würzburg, Germany
| | | | | | | | | | | |
Collapse
|
21
|
Ahmed N, Thornalley PJ, Lüthen R, Häussinger D, Sebekova K, Schinzel R, Voelker W, Heidland A. Processing of protein glycation, oxidation and nitrosation adducts in the liver and the effect of cirrhosis. J Hepatol 2004; 41:913-9. [PMID: 15582123 DOI: 10.1016/j.jhep.2004.08.007] [Citation(s) in RCA: 55] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/29/2004] [Revised: 07/21/2004] [Accepted: 08/01/2004] [Indexed: 01/31/2023]
Abstract
BACKGROUND/AIMS Plasma proteins are modified non-enzymatically in vivo by glycation, oxidation and nitrosation processes. Hepatic extraction of albumin glycated in vitro was reported but it is not clear if plasma proteins glycated in vivo also undergo hepatic extraction. We investigated the hepatic extraction of glycated, oxidised and nitrosated proteins in vivo. METHODS Protein glycation, oxidation and nitrosation marker residues and free adducts were determined in portal, hepatic and peripheral venous blood plasma of cirrhotic patients and hepatic and peripheral venous blood plasma (as a surrogate of portal venous blood) of control subjects by liquid chromatography-mass spectrometry. RESULTS There was no evidence for extraction of glycated, oxidised or nitrosated proteins or related free adducts by the liver in control subjects. There was limited extraction of methylglyoxal-modified proteins in cirrhotic patients and twofold increases in the concentrations of fructosyl-lysine and advanced glycation endproduct residues of plasma protein, with respect to controls. Remarkably, glyoxal-derived hydroimidazolone free adduct was increased 14-16-fold probably as a consequence of hepatic lipid peroxidation. CONCLUSIONS We found no evidence for hepatic extraction of glycated, oxidised and nitrosated proteins or related free adducts in subjects with normal liver function and limited extraction of methylglyoxal-modified protein in cirrhotic subjects.
Collapse
Affiliation(s)
- Naila Ahmed
- Department of Biological Sciences, University of Essex, Wivenhoe Park, Central Campus, Colchester, Essex CO4 3SQ, UK
| | | | | | | | | | | | | | | |
Collapse
|
22
|
Teschner M, Heidland A, Klassen A, Sebekova K, Bahner U. Georg Ganter--a pioneer of peritoneal dialysis and his tragic academic demise at the hand of the Nazi regime. J Nephrol 2004; 17:457-60. [PMID: 15365972] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/30/2023]
Abstract
First reports in German literature on the effective removal of uremic toxins by means of extracorporeal hemodialysis in bi-nephrectomized, acute uremic dogs were given by Heinrich Necheles and Georg Haas. These methods were viewed with great scepticism by Georg Ganter who criticized in particular the extensive operative procedure by use of the femoral artery and vein, the size and fragility of the dialysers, as well as the potential toxic effects of the anticoagulant hirudin. As an alternative approach, he suggested the use of the peritoneum as an especially large endogenous dialysis membrane. In 1923, in experiments on ureter-ligated guinea pigs and rabbits, he demonstrated that the single or repeated instillation (after effective draining) of physiological NaCl solution improves both the symptoms of uremia and the blood urea nitrogen level. In patients this new procedure was implemented only sporadically and in the form of a single fluid instillation after a first observation in a uremic patient where a pleura exudate was substituted: in a female patient with acute uremia as a consequence of a ureter occlusion, due to uterus carcinoma, and in a patient with a diabetic coma. In spite of these limited experiences, Ganter was convinced of the superiority of his method over the troublesome hemodialysis therapy and recommended its broader clinical application.
Collapse
Affiliation(s)
- Markus Teschner
- Kuratorium for Dialysis and Kidney Transplantation, Würzburg, Germany
| | | | | | | | | |
Collapse
|
23
|
Klassen A, Bahner U, Sebekova K, Heidland A. [The importance of overweight and obesity for the development and progression of renal diseases]. Dtsch Med Wochenschr 2004; 129:579-82. [PMID: 14997412 DOI: 10.1055/s-2004-820548] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Affiliation(s)
- A Klassen
- Medizinische Klinik der Universität Wuerzburg
| | | | | | | |
Collapse
|
24
|
Abstract
In patients with chronic renal failure, cancer incidence is enhanced. Since levels of advanced glycation end products (AGEs) are markedly elevated in renal insufficiency, we investigated potential effects of various AGEs on structural DNA integrity in tubule cells. The comet-assay was employed, a method based on the computer-aided microscopic analysis of single cells after electrophoretic separation of their nuclear DNA. Incubation of pig kidney LLC-PK1-cells for 24 h with AGE-BSA (AGE-bovine serum albumin), carboxymethyllysine-BSA as well as methylglyoxal-BSA resulted in a significant increase in DNA damage. Pretreatment of the cells with the proteases trypsin and bromelain abolished the AGE-induced comet-formation. This is in agreement with the idea that the observed genotoxicity of AGEs could be receptor-mediated and that proteases inactivate the extracellular domain of the receptor for AGEs. Binding of AGEs to the RAGE receptor leads to an increased intracellular formation of active oxygen species, which are known to induce DNA damage. It is concluded that AGEs induce genotoxicity in tubule cells, which may be involved in the enhanced cancer development in advanced kidney diseases.
Collapse
Affiliation(s)
- Helga Stopper
- Department of Pharmacology and Toxicology, University of Würzburg, Versbacher Strasse 9, D-97078, Würzburg, Germany.
| | | | | | | |
Collapse
|
25
|
Faist V, Hofmann T, Zill H, Baynes J, Thorpe S, Sebekova K, Schinzel R, Heidland A, Wenzel E, Erbersdobler H. Effects of dietary Nε-carboxymethyllysine on expression of the biotransformation enzyme, glutathione-S-transferase, in the rat. ACTA ACUST UNITED AC 2002. [DOI: 10.1016/s0531-5131(02)01152-4] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
26
|
Paczek L, Gaciong Z, Bartlomiejczyk I, Sebekova K, Birkenmeier G, Heidland A. Protease administration decreases enhanced transforming growth factor-beta 1 content in isolated glomeruli of diabetic rats. Drugs Exp Clin Res 2002; 27:141-9. [PMID: 11822224] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/23/2023]
Abstract
Overproduction of transforming growth factor (TGF)-beta 1 messenger RNA is of fundamental importance in the pathogenesis of diabetic nephropathy. In vitro studies have recently shown that the serine protease trypsin diminishes the enhanced TGF-beta 1-expression induced by advanced glycation end products. Moreover, proteolytic enzymes may accelerate the removal of TGF-beta 1 from renal tissue via a protease-induced activation of alpha 2-macroglobulin (alpha 2M). This activation results in the binding of numerous cytokines, including TGF-beta 1 and is followed by enhanced plasma clearance of the protease alpha 2M-cytokine complex. In the present study in streptozotocin-diabetic rats we investigated whether the administration of Phlogenzym, a fixed combination of the proteases trypsin and bromelain combined with the antioxidant rutosid, modulates renal hypertrophy and the formation of TGF-beta 1 in isolated glomeruli. Three weeks after induction of diabetes, renal hypertrophy developed with an enhanced kidney/body weight ratio. When compared with normal rats, an elevated content of intraglomerular TGF-beta 1 (44.25 +/- 21.9 vs. 71.1 +/- 23.4 ng/microgram DNA, p < 0.05) as well as fibronectin (2.62 +/- 0.49 vs. 3.42 +/- 0.62 ng/microgram DNA, p < 0.05) was observed. In the diabetic rats, treatment with intraperitoneal proteases prevented the rise of intraglomerular TGF-beta 1 content (34.9 +/- 22.2 ng/microgram DNA, p < 0.01) and attenuated the rise of fibronectin (3.03 +/- 1.12 ng/microgram DNA NS). Furthermore, a decrease in the kidney/body weight ratio (p < 0.01) was achieved. Protease administration did not affect blood glucose concentration and was without visible adverse effects.
Collapse
Affiliation(s)
- L Paczek
- Transplantation Institute, Warsaw School of Medicine, Nowogrodzka Street, 02-006 Warsaw, Poland
| | | | | | | | | | | |
Collapse
|
27
|
Sebekova K, Spustova V, Opatrny K, Dzurik R. Serotonin and 5-hydroxyindole-acetic acid. BRATISL MED J 2002; 102:351-6. [PMID: 11763663] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/23/2023]
Abstract
BACKGROUND In patients suffering from chronic renal insufficiency (CRI) serotonin (5HT) metabolism is impaired, and plasma 5-hydroxyindoleacetic acid (5HIAA) levels (main metabolite of 5HT) are increased. AIM In this study we aimed to give a detailed description of peripheral serotonin metabolism in healthy subjects and patients with CRI, and to evaluate the efficacy of hemodialysis in the elimination of cumulated 5HT and 5HIAA. METHODS 5HT (platelet rich plasma, platelet poor plasma, urine, HPLC with electrochemical detection) and 5HIAA (plasma, urine, HPCL with electrochemical detection) levels were evaluated in 14 conservatively treated (CT) and 12 hemodialysed (HD) patients with CRI and were compared to those of 60 healthy volunteers (HV). RESULTS In patients with CRI accumulation of 5HT and 5HIAA in plasma with no changes in platelet 5HT content was revealed. 5HT renal and fractional excretion (FE) was markedly decreased in CRI. FE-5HT was < 1 in all investigated subjects, indicating its reabsorption in proximal tubules, or local degradation to 5HIAA. Due to the increased filtration load renal excretion of 5HIAA was not altered in CT patients, however it was decreased in HD patients. The relative participation of glomerular filtration in 5HIAA renal excretion increased in CRI. FE-5HIAA > 5 was found in 20% of HV and 15% of CT, pointing indirectly to 5HIAA intrarenal production. In CRI FE-5HIAA decreased. HD did not eliminate accumulated 5HT and 5HIAA effectively. CONCLUSION Increased levels of 5HT and 5HIAA might exert metabolic effects contributing to the clinically manifested impairments characteristic for uremic syndrome. (Tab. 3, Fig. 3, Ref. 27.)
Collapse
Affiliation(s)
- K Sebekova
- Institute of Preventive and Clinical Medicine, Bratislava, Slovakia.
| | | | | | | |
Collapse
|
28
|
Abstract
In experimental and human diabetic nephropathy (DN), it has been shown that advanced glycation end products (AGEs), in particular, carboxymethyl-lysine and pentosidine, accumulate with malondialdehyde in glomerular lesions in relation to disease severity and in the presence of an upregulated receptor for AGE (RAGE) in podocytes. Toxic effects of AGEs result from structural and functional alterations in plasma and extracellular matrix (ECM) proteins, in particular, from cross-linking of proteins and interaction of AGEs with their receptors and/or binding proteins. In mesangial and endothelial cells, the AGE-RAGE interaction caused enhanced formation of oxygen radicals with subsequent activation of nuclear factor-kappaB and release of pro-inflammatory cytokines (interleukin-6, tumor necrosis factor-alpha), growth factors (transforming growth factor-beta1 [TGF-beta1], insulin-like growth factor-1), and adhesion molecules (vascular cell adhesion molecule-1, intercellular adhesion molecule-1). In tubular cells, incubation with AGE albumin was followed by stimulation of the mitogen-activating protein (MAP) kinase pathway and its downstream target, the activating protien-1 (AP-1) complex, TGF-beta1 overexpression, enhanced protein kinase C activity, decreased cell proliferation, and impaired protein degradation rate, in part caused by decreased cathepsin activities. The pathogenic relevance of AGEs was further verified by in vivo experiments in euglycemic rats and mice by the parenteral administration of AGE albumin, leading in the glomeruli to TGF-beta1 overproduction, enhanced gene expression of ECM proteins, and morphological lesions similar to those of DN. Evidence for the pathogenic relevance of AGEs in DN also comes from experimental studies in which the formation and/or action of AGEs was modulated by aminoguanidine, OPB-9195, pyridoxamine, soluble RAGEs, serine protease trypsin, and antioxidants, resulting in improved cell and/or renal function.
Collapse
Affiliation(s)
- A Heidland
- Department of Internal Medicine and Physiologische Chemie I, University of Würzburg, Germany.
| | | | | |
Collapse
|
29
|
Xiang G, Schinzel R, Simm A, Münch G, Sebekova K, Kasper M, Niwa T, Schmitz C, Heidland A. Advanced glycation end products (AGEs)-induced expression of TGF-beta 1 is suppressed by a protease in the tubule cell line LLC-PK1. Nephrol Dial Transplant 2001; 16:1562-9. [PMID: 11477156 DOI: 10.1093/ndt/16.8.1562] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023] Open
Abstract
BACKGROUND Advanced glycation end products (AGEs) are assumed to play a key role in diabetic nephropathy (DN). Since little is known about their action in tubule cells, we investigated in LLC-PK1 cells: (i) whether AGE-bovine serum albumin (AGE-BSA) affects cell proliferation and expression of transforming growth factor-beta (TGF-beta 1); and (ii) whether the AGE-induced effects can be modulated by trypsin due to interference with its binding proteins at the cell surface. METHODS Arrested cells were exposed to vehicle (control), AGE-BSA (19--76 microM) and BSA (38 microM) in the presence or absence of trypsin (0.625--5.0 microg/ml) (2.5 microg/ml) for 24 h. We evaluated cell proliferation by cell count and by [(3)H]thymidine incorporation, TGF-beta 1 expression by reverse transcription-polymerase chain reaction (RT-PCR), and TGF-beta 1 protein by ELISA. In addition, cell accumulation of AGEs was studied by immunohistochemical staining of the AGE imidazolone. RESULTS AGE-BSA inhibited [(3)H]thymidine incorporation, lowered cell number and increased cell protein content as well as TGF-beta 1 mRNA and protein as compared with control and BSA. Immunohistochemical staining revealed a marked intracellular accumulation of the AGE imidazolone. Co-incubation of AGE-BSA with trypsin ameliorated the impaired thymidine incorporation, the decreased cell count and the enhanced cell protein content. TGF-beta 1 overexpression was normalized, while TGF-beta 1 protein declined insignificantly. Intracellular imidazolone accumulation was strikingly suppressed. CONCLUSIONS In the tubule cell line LLC-PK1, AGE-BSA exerts an antiproliferative effect, most probably due to TGF-beta 1 overproduction. The co-administration of trypsin abrogated this alteration, very likely as a result of an interaction with AGE-binding protein(s), which is supported by the decreased intracellular AGE accumulation. These findings may be the starting point for the development of specific proteolytic enzymes to interfere with the interaction between AGEs and their receptors/binding proteins.
Collapse
Affiliation(s)
- G Xiang
- Department of Internal Medicine and Institute of Physiological Chemistry, University of Würzburg, Germany
| | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Schinzel R, Münch G, Heidland A, Sebekova K. Advanced glycation end products in end-stage renal disease and their removal. Nephron Clin Pract 2001; 87:295-303. [PMID: 11287772 DOI: 10.1159/000045934] [Citation(s) in RCA: 44] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
|
31
|
Sebekova K, Heidland A. [Diabetic nephropathy: new findings on pathogenesis and therapy]. BRATISL MED J 2001; 101:580-1. [PMID: 11218950] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
Abstract
The authors describe the new factors (genetic, haemodynamic and metabolic) which are involved in the pathogenesis and therapy of diabetic nephropathy. The treatment must be based especially on strict control of glycaemia, decrease in arterial blood pressure, beneficial effect of low-protein diet, reduction of body weight and smoking prevention. The combination of the presented therapeutic procedures can slow down the progression of nephropathy and approximate it to the process of natural ageing.
Collapse
Affiliation(s)
- K Sebekova
- Klinika farmakoterapie, Ustav preventívnej a klinickej medicíny, Limbová 14, Bratislava, a Univerzita Würzburg, Nemecko.
| | | |
Collapse
|
32
|
Krivosikova Z, Dusinska M, Spustova V, Sebekova K, Blazicek P, Heidland A, Dzurik R. DNA damage of lymphocytes in experimental chronic renal failure: Beneficial effects of losartan. Kidney Int 2001. [DOI: 10.1046/j.1523-1755.2001.07807.x] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
33
|
Xiang G, Schinzel R, Simm A, Sebekova K, Heidland A. Advanced glycation end products impair protein turnover in LLC-PK1: amelioration by trypsin. Kidney Int Suppl 2001; 78:S53-7. [PMID: 11168983 DOI: 10.1046/j.1523-1755.2001.59780053.x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
BACKGROUND Advanced glycation end products (AGEs) are assumed to play a key role in the pathogenesis of diabetic nephropathy (DN) and other diabetic complications. While AGEs have been shown to exert marked effects on mesangial and endothelial cells as well as on monocytes/macrophages, little is known about their effects on tubule cells. Therefore, we addressed the questions of (1) whether AGE-bovine serum albumin (AGE-BSA) impairs the protein metabolism in the tubule cells, and if so, (2) whether the AGE-induced effects are mediated via a protease sensitive mechanism. METHODS Arrested LLC-PK1 cells were exposed to a medium containing the vehicle (control, serum free), AGE-BSA (38 micromol/L), or BSA (38 micromol/L) in the presence or absence of trypsin (2.5 microg/mL) for 24 hours. We evaluated cell number, cell size, and cell protein content, as well as protein synthesis and protein degradation. RESULTS After an incubation period of 24 hours, AGE-BSA decreased the cell number to 84.5 +/- 5.5% of control and 82.5 +/- 5.6% of BSA-treated cells (P < 0.05). [3H]-thymidine incorporation declined to 66% of control (P < 0.05), while BSA was without any effect. The same AGE-BSA dose reduced protein degradation (P < 0.05) and stimulated total protein synthesis slightly, as determined by L-[14C]Phe incorporation into acidic-insoluble proteins. These effects resulted in a rise in cell protein content (AGE-BSA vs. control, 21.9 +/- 6.7%; AGE-BSA vs. BSA, 11.1 +/- 6.0%, P < 0.05) and cell volume (AGE-BSA vs. control 9.4 +/- 3.2%, AGE-BSA vs. BSA 18.4 +/- 3.7%, P < 0.05). Coincubation with AGE-BSA and trypsin was associated with an amelioration of all investigated parameters concerning cell number, cell proliferation, raised cell protein content, decreased protein degradation, and enhanced protein synthesis. CONCLUSION These data indicate that AGE-BSA impairs cell proliferation and protein turnover in LLC-PK1 cells with a consequent rise in cell protein. Since these alterations were abrogated by coincubation with trypsin, an interference of this serine protease with the AGE-binding proteins on cell surfaces is assumed.
Collapse
Affiliation(s)
- G Xiang
- Department of Internal Medicine, Institute of Physiological Chemistry, University of Würzburg, Würzburg, Germany
| | | | | | | | | |
Collapse
|
34
|
Sebekova K, Blazicek P, Syrova D, Krivosikova Z, Spustova V, Heidland A, Schinzel R. Circulating advanced glycation end product levels in rats rapidly increase with acute renal failure. Kidney Int 2001. [DOI: 10.1046/j.1523-1755.59.s78.10.x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
35
|
Sebekova K, Blazicek P, Syrova D, Krivosikova Z, Spustova V, Heidland A, Schinzel R. Circulating advanced glycation end product levels in rats rapidly increase with acute renal failure. Kidney Int 2001. [DOI: 10.1046/j.1523-1755.2001.07808.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
36
|
Xiang G, Schinzel R, Simm A, Sebekova K, Heidland A. Advanced glycation end products impair protein turnover in LLC-PK1: Amelioration by trypsin. Kidney Int 2001. [DOI: 10.1046/j.1523-1755.2001.07840.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
37
|
Heidland A, Gerabek W, Sebekova K. Franz Volhard and Theodor Fahr: achievements and controversies in their research in renal disease and hypertension. J Hum Hypertens 2001; 15:5-16. [PMID: 11223997 DOI: 10.1038/sj.jhh.1001130] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
The clinician, Franz Volhard, and the pathologist, Theodor Fahr, worked closely together in Mannheim from 1909 until 1915 and introduced a novel classification of renal diseases. In the monograph entitled 'Die Bright'sche Nierenkrankheit, Klinik, Pathologie und Atlas' (1914) they differentiated between degenerative (nephroses), inflammatory (nephritides) and arteriosclerotic (scleroses) diseases. Nephrosclerosis was divided into the benign and malignant form, of which the latter stood the test of time as a new disease entity. Fahr further divided benign nephrosclerosis into the compensated and decompensated form--depending on the presence or absence of glomerular injury. In the pathogenesis of malignant nephrosclerosis, Volhard stressed the decisive role of severe blood pressure elevation, while Fahr postulated an inflammatory mechanism, a concept later confirmed by Adalbert Bohle for at least a minority of patients. A very far reaching concept of Franz Volhard was his idea that pale (renal) hypertension results from a pressor substance released from ischaemic kidney(s) contributing--via a vicious circle--to a further rise in blood pressure with subsequent renovascular injury and aggravation of hypertension. This hypothesis was supported in 1930 by initial experiments of his collaborator, Hartwich (demonstrating in dogs a mild rise in blood pressure after ligation of branches of the renal artery) and definitively proven by Goldblatt (1934) in dogs by induction of severe and persistent hypertension after clamping of both renal arteries. The consequent detection of the renin angiotensin system was the final confirmation of Volhard's postulated renal pressor substance. In the pathogenesis of red (essential) hypertension, Volhard stressed the role of hereditary factors, age, obesity and potentially of severe alcoholism. He emphasised a premature reduction of vascular distensibility (due to elastosis of the prearterioles), a high cardiac output as well as a dampening of baroceptor function. Additionally, Volhard made crucial advances in cardiology and pneumology. Journal of Human Hypertension (2001) 15, 5-16
Collapse
Affiliation(s)
- A Heidland
- Department of Internal Medicine, University of Wuerzburg, Germany
| | | | | |
Collapse
|
38
|
Sebekova K, Stefikova K, Krivosikova Z, Spustova V. 31P NMR investigation of free intracellular magnesium, pH and energy balance in striated muscle of patients with kidney disease: relation to insulin resistance. BRATISL MED J 1999; 100:411-6. [PMID: 10645027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/15/2023]
Abstract
BACKGROUND High prevalence (48%) of insulin resistance (IR) in patients with mild to moderate kidney function reduction, and the potential pathogenetic role of magnesium (Mg) deficiency in IR prompted us to study skeletal muscle free Mg (fMg) concentration in patients with impaired kidney function. METHODS fMg concentration, intracellular pH (pHi) and parameters of energy balance were determined employing 31P NMR spectroscopy in the calf muscle of the dominant leg of 18 healthy controls (C) and 22 patients (P) with decreased kidney function. 10 patients suffered from insulin resistance (IR). RESULTS No difference in fMg concentration in skeletal muscle was observed (C: 0.929 +/- 0.075; P: 0.948 +/- 0.062 mmol/l; x +/- SEM). In patients a slight shift of pHi towards acidic values was found (C: 7.036 +/- 0.0.004; P: 7.013 +/- 0.004; p < 0.004), which was even more expressed in IR patients (7.008 +/- 0.005). Serum creatinine levels and creatinine clearance correlated with pHi in the patient's group. Adenosintriphosphate (ATP) to inorganic phosphate (Pi) ratio in skeletal muscle was lower, phosphocreatine (Pcr)/ATP ratio was higher, while that of Pcr/Pi showed only a trend towards an increase in the patient's group. CONCLUSION In patients with reduction of kidney function IR does not associate with a change in skeletal muscle free magnesium concentration, or deficiency in macroergic phosphate levels. Shift in intracellular pH towards acidic values may participate in IR. Decreased activity of Na+/H+ antiporter is suggested. (Fig. 5, Tab. 2, Ref. 22.)
Collapse
Affiliation(s)
- K Sebekova
- Clinic of Pharmacotherapy, Institute of Preventive and Clinical Medicine, Bratislava.
| | | | | | | |
Collapse
|
39
|
Huang S, Schaefer RM, Reisch S, Paczek L, Schaefer L, Teschner M, Sebekova K, Heidland A. Suppressed activities of cathepsins and metalloproteinases in the chronic model of puromycin aminonucleoside nephrosis. Kidney Blood Press Res 1999; 22:121-7. [PMID: 10394110 DOI: 10.1159/000025917] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023] Open
Abstract
Glomerulosclerosis and tubulointerstitial fibrosis are the hallmarks of chronic renal diseases. In the present study, we have investigated the potential involvement of various proteinases in these alterations in the model of puromycin aminonucleoside (PAN) nephrosis. Two groups of male Wistar rats were given either three or seven injections of PAN (2.0 mg/100 g body weight) over a 4- and 12-week period, respectively. The two control groups received saline injections. Activities of cathepsins (B, H and L) were determined in isolated glomeruli and proximal tubules. Moreover, collagenase-like and gelatinase-like activities were analyzed in isolated glomeruli. Three weeks after weekly PAN injection, the rats developed heavy proteinuria (140.8+/-22.0 vs. 13.5+/-3.29 mg/day; p<0.001), and at week 11 protein excretion reached 606.6+/-23.00 vs. 22.8+/-1.5 mg/day. Renal morphology revealed minimal glomerular mesangial changes at the 4th week after PAN administration. At the 12th week a marked mesangial matrix accumulation as well as severe tubulointerstitial infiltration and fibrosis associated with tubular dilation and atrophy were observed. Glomerular cathepsins B, H, and L and gelatinase-like activities decreased at the 4th week after the first PAN injection and remained at this low level throughout the entire study period. Glomerular collagenase-like activity decreased at the 4th week (p<0.05) and was still mildly lower than that of the control group at the 12th week, but without significance. In the isolated proximal tubules, the activities of cathepsins B, H, and L showed the same pattern of decreases as those found in the glomeruli over the whole experimental period. Taken together, our data in the model of chronic PAN nephrosis suggest that the suppressed activities of cathepsins as well as the decreased gelatinase- and collagenase-like activities participate in the accumulation of extracellular matrix and thereby may contribute to the development of glomerulosclerosis and tubulointerstitial fibrosis.
Collapse
Affiliation(s)
- S Huang
- Faculty of Medicine, University of Würzburg, Germany
| | | | | | | | | | | | | | | |
Collapse
|
40
|
Ling H, Ardjomand P, Samvakas S, Simm A, Busch GL, Lang F, Sebekova K, Heidland A. Mesangial cell hypertrophy induced by NH4Cl: role of depressed activities of cathepsins due to elevated lysosomal pH. Kidney Int 1998; 53:1706-12. [PMID: 9607203 DOI: 10.1046/j.1523-1755.1998.00952.x] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Enhanced ammoniagenesis is currently thought to play an important role in renal hypertrophy and subsequent tubulointerstitial fibrosis. Under certain conditions glomeruli also may be affected by ammonia toxicity. Exposure of glomeruli to augmented ammonia levels may occur: (i) in advanced liver diseases due to elevated blood ammonia concentrations; (ii) in conditions of enhanced tubular ammoniagenesis following cortical "trapping;" and (iii) due to increased ammonia formation in the glomeruli in the presence of impaired renal function. To elucidate the potential role of ammonia in glomerular injury, we investigated the effect of NH4Cl on protein turnover as well as on activities of various cathepsins in cultured rat mesangial cells. The results show that NH4Cl (20 mM) induced cell hypertrophy as defined by an increase in both cell protein content and cell volume (+38% and +10.1%, respectively, after 48 hr). This hypertrophy was associated with suppression of the activities of cathepsins B and L + B (-56.8% and -51.3% after 48 hr) and reduction of protein degradation rate (-61% after 48 hr), but without enhanced protein synthesis. Inhibition of Na+/H+ antiport by amiloride (1 mM) neither prevented the reduction of cathepsin activities nor the hypertrophy of the mesangial cells. Upon NH4Cl application lysosomal pH was elevated. This alkalinization may be causatively involved in the impairment of cathepsin B and L + B due to shifting the lysosomal pH above the optimum of their activities. In conclusion, NH4Cl induces hypertrophy but not hyperplasia in mesangial cells. This hypertrophy is caused by the reduction of protein degradation, mainly due to depressed activities of cathepsin B and L + B in the absence of enhanced protein synthesis. A shift of lysosomal pH above the optimum of the acidic cathepsins seems to be a key factor in their impaired activities in mesangial cells.
Collapse
Affiliation(s)
- H Ling
- Division of Nephrology, University of Wuerzburg, Germany
| | | | | | | | | | | | | | | |
Collapse
|
41
|
Heidland A, Schinzel R, Sebekova K, Xiang G, Münch G, Simm A. Advanced glycation endproducts and the kidney. Przegl Lek 1998; 55 Suppl 1:29-31. [PMID: 9857688] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/11/2023]
Affiliation(s)
- A Heidland
- Dept. of Int. Med., Univ. of Würzburg, Germany
| | | | | | | | | | | |
Collapse
|
42
|
Sebekova K, Paczek L, Dämmrich J, Ling H, Spustova V, Gaciong Z, Heidland A. Effects of protease therapy in the remnant kidney model of progressive renal failure. Miner Electrolyte Metab 1997; 23:291-5. [PMID: 9387136] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
This study investigated whether protease treatment ameliorates the progressive course of chronic failure in the rat model of subtotal nephrectomy. Fourteen male Wistar rats underwent 5/6 nephrectomy, and were randomized into a control group (C, n = 7) given 2 ml of 0.9% NaCl intraperitoneally (i.p.) daily, and a study group (P, n = 7) treated with 12 mg Phlogenzym (combination of trypsin, bromelain, and rutosid) in 2 ml saline i.p. daily. After 6 weeks treatment, the Phlogenzym group showed lower proteinuria (C: 19.6 +/- 9.1 vs. 10.2 +/- 6.2 mg/24 h, p < 0.05). Endogenous creatinine clearance was higher (C: 192.3 +/- 99.4, P: 300.5 +/- 47.9 microliters/min per 100 g, p < 0.05), while plasma creatinine was decreased (C: 106.7 +/- 33.9, P: 76.0 +/- 6.3 mumol/l, p < 0.01). Blood urea nitrogen levels did not change, although urea clearance tended to a higher level in the protease-treated rats. Decreased renal formation of cytokines was reflected by a lower urinary excretion ratio of transforming growth factor (TGF)-beta/ creatinine (C: 0.363 +/- 0.183, P: 0.232 +/- 0.085 ng TGF-beta/mg creatinine, p < 0.05). Renal morphology revealed less infiltration of mononuclear cells and an amelioration of interstitial fibrosis as expressed by the volume index of the cortical region (C: 17.17 +/- 1.43; P: 12.3 +/- 0.5%, p < 0.001). In addition, the activities of lysosomal proteinases (cathepsin B, L + B, and H), which are decreased in the remnant kidney model of chronic renal failure, were significantly higher in the enzyme-treated group both in isolated glomeruli and proximal tubules. The body and kidney weight tended to be lower, probably due to a catabolic action of the enzymes. In summary, we provide evidence that protease treatment may be beneficial in a nonimmune mediated renal disease. Phlogenzym ameliorated the course of chronic renal failure in the rat model of subtotal nephrectomy and retarded the development of tubulointerstitial fibrosis. Decreased cytokine formation in the remnant kidney is supposed to play a key role.
Collapse
Affiliation(s)
- K Sebekova
- Institute of Preventive and Clinical Medicine, Bratislava, Slowakia
| | | | | | | | | | | | | |
Collapse
|
43
|
Heidland A, Sebekova K, Paczek L, Teschner M, Dämmrich J, Gaciong Z. Renal fibrosis: role of impaired proteolysis and potential therapeutic strategies. Kidney Int Suppl 1997; 62:S32-5. [PMID: 9350675] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Affiliation(s)
- A Heidland
- Kuratorium for Dialysis and Kidney Transplantation, University of Wuerzburg, Germany
| | | | | | | | | | | |
Collapse
|